Innovative Medicines Canada

Innovative Medicines Canada is a coalition of pharmaceutical companies that represents the interests of the pharmaceutical industry in Canada.

IMC is represented on the board of directors for the Pharmaceutical Advertising Advisory Board by Crawford Wright.¹⁾ It is also partnered with the Best Medicines Coalition.²⁾

The Chair of the Board of Directors for IMC is Cole Pinnow, President of Pfizer Canada.³⁾

The following is the list of companies displayed on the Member Companies page of IMC's website, and in their Annual Reports.^{4) 5)}

Canada’s Health Research Foundation (HRF) is a non-profit organization that invests in health research in Canadian academic centres, and promotes the benefits and values of research-driven health innovation in Canada. Innovative Medicines Canada members “generously contribute a million dollars annually to the HRF ensuring such research will continue to benefit Canadians for years to come.”⁶⁾

Innovative Medicines Canada lobbies Doug Ford's Government of Ontario through lobbying firm Rubicon Strategy.^{7) 8)} The company seeks to “collaborate with government to ensure ‘Transfer of Value’ Regulations avoid unintended consequences and support a sustainable, balanced and credible approach” surrounding the “Health Sector Payment Transparency ACT”.⁹⁾